HK1225739A1 - 針對肺炎鏈球菌進行保護的富含脯氨酸的肽 - Google Patents

針對肺炎鏈球菌進行保護的富含脯氨酸的肽

Info

Publication number
HK1225739A1
HK1225739A1 HK16113900A HK16113900A HK1225739A1 HK 1225739 A1 HK1225739 A1 HK 1225739A1 HK 16113900 A HK16113900 A HK 16113900A HK 16113900 A HK16113900 A HK 16113900A HK 1225739 A1 HK1225739 A1 HK 1225739A1
Authority
HK
Hong Kong
Prior art keywords
pneumoniae
proline
protective against
rich peptides
peptides protective
Prior art date
Application number
HK16113900A
Other languages
English (en)
Inventor
Arin Ghasparian
Armando Zuniga
Nina Geib
Marco Tamborini
Maja Jud
Gerd Pluschke
Nodarse Aniebrys Marrero
John Anthony Robinson
Original Assignee
Virometix Ag
Swiss Tropical And Public Health Inst
Univ Basel
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virometix Ag, Swiss Tropical And Public Health Inst, Univ Basel, Univ Zuerich filed Critical Virometix Ag
Publication of HK1225739A1 publication Critical patent/HK1225739A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16023—Virus like particles [VLP]
HK16113900A 2013-12-03 2016-12-06 針對肺炎鏈球菌進行保護的富含脯氨酸的肽 HK1225739A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13195402 2013-12-03

Publications (1)

Publication Number Publication Date
HK1225739A1 true HK1225739A1 (zh) 2017-09-15

Family

ID=49765797

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16113900A HK1225739A1 (zh) 2013-12-03 2016-12-06 針對肺炎鏈球菌進行保護的富含脯氨酸的肽

Country Status (12)

Country Link
US (2) US9943583B2 (zh)
EP (1) EP3077410B1 (zh)
JP (2) JP2017501990A (zh)
KR (1) KR20160088323A (zh)
CN (1) CN105793276A (zh)
AU (1) AU2014359292B2 (zh)
BR (1) BR112016012306A2 (zh)
CA (1) CA2931570A1 (zh)
HK (1) HK1225739A1 (zh)
RU (1) RU2737638C2 (zh)
WO (1) WO2015082501A1 (zh)
ZA (1) ZA201603962B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3016815A1 (en) * 2016-03-08 2017-09-14 KeMyth Biotech Co., Ltd. Use of pneumolysin peptides as antagonists against toll-like receptor 4 and methods of treating toll-like receptor 4 related diseases
JP7246644B2 (ja) * 2016-12-03 2023-03-28 ザ ユーエービー リサーチ ファウンデイション 肺炎球菌表面プロテインａの選択されたアルファヘリカルドメインおよびプロリンリッチドメインを組み合わせた肺炎球菌ワクチン
RU2019142012A (ru) 2017-06-14 2021-07-14 Вирометикс Аг Циклические пептиды для защиты от респираторно-синцитиального вируса
CN108559784B (zh) * 2018-07-06 2021-08-20 陕西省动物研究所 一种同时检测三种病原菌的三重pcr检测用引物、探针、试剂盒及检测方法
AU2019408048A1 (en) * 2018-12-20 2021-06-24 Universität Zürich Lipopeptide building blocks and synthetic virus-like particles
WO2021260176A1 (en) 2020-06-25 2021-12-30 Virometix Ag Synthetic epitopes of betacoronaviruses
WO2022063990A1 (en) 2020-09-28 2022-03-31 Dbv Technologies Particle comprising an rsv-f protein for use in rsv vaccination

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
GB8704647D0 (en) 1987-02-27 1987-04-01 Guy S & St Thomas S Hospitals Vaccine
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US5391712A (en) 1991-08-30 1995-02-21 Beckman Instruments, Inc. Non-hemolytic streptolysin O variants
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
US6251405B1 (en) 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
EP0907738A1 (en) 1996-04-02 1999-04-14 Smithkline Beecham Corporation Novel compounds
JP2000508178A (ja) 1996-05-14 2000-07-04 スミスクライン・ビーチャム・コーポレイション 新規化合物
US6096863A (en) 1996-08-23 2000-08-01 Regents Of The University Of Minnesota Self-assembling amphiphiles for construction of peptide secondary structures
EP1400592A1 (en) 1996-10-31 2004-03-24 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
CA2312900A1 (en) 1997-12-02 1999-06-10 Powderject Vaccines, Inc. Transdermal delivery of particulate vaccine compositions
IT1320157B1 (it) 2000-01-27 2003-11-18 Combistone Italia S P A Piano e/o rivestimento per arredamento e procedimento per la suaproduzione.
EP2284181A1 (en) 2000-10-27 2011-02-16 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups A and B
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
CN101124237A (zh) 2001-04-13 2008-02-13 惠氏 酿脓链球菌的表面蛋白
GB0210128D0 (en) 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
ES2504166T3 (es) 2002-09-13 2014-10-08 Novartis Vaccines And Diagnostics, Inc. Vacuna de estreptococo del grupo B
MXPA05013260A (es) 2003-06-26 2006-03-09 Chiron Corp Composiciones inmunogenicas para chlamydia trachomatis.
ATE536370T1 (de) 2006-02-02 2011-12-15 Univ Alabama Res Found Nicht gespulte schutzregionen der pneumokokken- oberflächenproteine pspa und pspc
JP5276598B2 (ja) * 2006-12-09 2013-08-28 ウニヴェルジテート チューリッヒ プロレクトラート エムエヌヴェー コイルドコイル構造を有するリポペプチドビルディングブロック、リポペプチドヘリックスバンドル、合成ウイルス様粒子、および医薬製剤
AU2012207088A1 (en) * 2011-01-20 2013-05-02 Children's Medical Center Corporation Vaccines and compositions against Streptococcus pneumoniae

Also Published As

Publication number Publication date
JP2017501990A (ja) 2017-01-19
RU2737638C2 (ru) 2020-12-01
WO2015082501A1 (en) 2015-06-11
US20160324947A1 (en) 2016-11-10
EP3077410B1 (en) 2021-02-03
ZA201603962B (en) 2020-02-26
BR112016012306A2 (pt) 2017-09-26
US9943583B2 (en) 2018-04-17
KR20160088323A (ko) 2016-07-25
EP3077410A1 (en) 2016-10-12
AU2014359292A1 (en) 2016-06-23
US20180256698A1 (en) 2018-09-13
CA2931570A1 (en) 2015-06-11
JP2020073487A (ja) 2020-05-14
AU2014359292B2 (en) 2019-02-28
CN105793276A (zh) 2016-07-20

Similar Documents

Publication Publication Date Title
HK1225739A1 (zh) 針對肺炎鏈球菌進行保護的富含脯氨酸的肽
HRP20180452T1 (hr) Peptidi
GB201411896D0 (en) .
GB201302863D0 (en) The Instaponytail
HK1196751A2 (zh) 保護套
GB201320677D0 (en) Protective cover
GB201315130D0 (en) Peptides
GB2519168C (en) Protective kerbstone cover
Monroe et al. AN APPEALING TIME
Fisher Caprichos
GB201519113D0 (en) Vehicle store
GB201409791D0 (en) .
GB201322661D0 (en) .
AP00658S1 (en) Tanqueray no. ten bottle
AU5064P (en) DBA-Aurora Triticum turgidum subsp. Durum
GB2516455B (en) Protective jacket
GB201300322D0 (en) Beataboutmusic.com
AU2013904172A0 (en) Push bike protective cover.
AU2013904719A0 (en) Protective cover
GB201312935D0 (en) T,b,s
GB201413121D0 (en) The E.M.S As Pripulsian
GB201314664D0 (en) Outboard platyfin
GB201320739D0 (en) The fold-a-way
GB201319475D0 (en) The wiperactive
GB201317585D0 (en) The dehydrometer